Skip to main content
2026 ACCP Annual Meeting Main banner
Final Program


Full Schedule

Full Schedule

  • Tuesday, September 29, 2026
  • 7:00 AM - 7:45 AM EDT
    STEP & ESP Gathering
  • 7:00 AM - 8:00 AM EDT
    Continental Breakfast
  • 7:00 AM - 3:30 PM EDT
    ACCP Registration Open
  • 8:00 AM - 9:30 AM EDT
    Symposium 10: HOT TOPIC: Maternal-Fetal & Neonatal Pharmacology: Integrating Clinical Insight & Modeling to Advance Drug Therapy in Fetal & Neonatal Care
    Co-Chair: Natalia V. de Moraes, PhD – Univ of Florida Coll of Pharmacy
    Co-Chair & Faculty: Jashvant Unadkat, PhD – Univ of Washington
    Co-Chair & Faculty: John N. van den Anker, MD, PhD – Children’s National Hosp
    Faculty: Christoph P. Hornik, MD, PhD – Duke Univ Medical Ctr
    Specific Populations/Rare Diseases
     CE: 1.5
  • 8:00 AM - 9:30 AM EDT
    Symposium 9: Maximizing Patient Outcomes: Immunogenicity Insights for Drug Development & Therapeutic Care
    Co-Chair & Faculty: Sihem Ait-Oudhia, PhD – Merck & Co Inc
    Co-Chair & Faculty: Bernd Meibohm, PhD – University of Tennessee Health Science Center
    Faculty: Eleni Caratzas, PhD (she/her/hers) – Johnson & Johnson
    Faculty: Michael Swanson, PhD – GlaxoSmithKline plc
    Faculty: Yow-Ming Wang, PhD – US Food & Drug Administration
    Novel Mechanisms & Emerging Therapeutic Modalities
     CE: 1.5
  • 9:30 AM - 10:00 AM EDT
    Coffee & Networking Break
  • 10:00 AM - 11:30 AM EDT
    Symposium 11: Transforming Clinical Pharmacology & Drug Safety: Enhancing Patient Safety Through Advanced Technology, Integrated Surveillance, Postmarket Strategies & Life Cycle Management
    Co-Chair & Faculty: Myong Jin Kim, PharmD
    Co-Chair & Faculty: Kyung-Sang Yu, MD, PhD – Seoul National Univ Hosp
    Faculty: Sara Camilli, PharmD – US Food & Drug Administration
    Faculty: Liang Zhao, PhD – Univ of California, San Francisco
    Artificial Intelligence/Technology Platforms from Drug Discovery to Patient Care
     CE: 1.5
  • 10:00 AM - 11:30 AM EDT
    Symposium 12: HOT TOPIC: Enabling Safe & Informed Therapeutics in Lactation: Role of the Clinical Pharmacologist
    Co-Chair & Faculty: Joga Gobburu, PhD – Univ of Maryland, Baltimore
    Co-Chair & Faculty: Elizabeth Lakota, PharmD, MS (she/her/hers) – Vertex Pharmaceuticals Ltd
    Faculty: Brooke Langevin, BS – Univ of Maryland
    Faculty: Sara Quinney, PharmD, PhD – Indiana Univ
    Specific Populations/Rare Diseases
     CE: 1.5
  • 11:30 AM - 1:30 PM EDT
    Lunch Buffet
  • 11:45 AM - 1:15 PM EDT
    Lunch & Annual Business Meeting (Open to all)
  • 1:30 PM - 3:00 PM EDT
    Symposium 13: Molecules, Models & Modalities from CAR-Ts to siRNAs: Clinical Pharmacology on the Frontier
    Chair & Faculty: Ahmed H. Salem, PhD, FCP – AbbVie Inc
    Faculty: Ahmed Nader, PhD – GlaxoSmithKline plc
    Faculty: Angela Parks – Servier
    Faculty: Ahmed M. Salem, PhD – AstraZeneca plc
    Novel Mechanisms & Emerging Therapeutic Modalities
     CE: 1.5
  • 1:30 PM - 3:00 PM EDT
    Symposium 14: Drug Dosing Equity for All Patients: Utilization of a Companion Drug Label
    Chair & Faculty: Daniel L. Weiner, PhD (he/him/his) – Univ of North Carolina
    Faculty: Jack Cook, PhD (he/him/his) – A2-Ai
    Faculty: Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke Univ
    Faculty: Norman Stockbridge, MD, PhD – S & S Consulting Partners LLC
    Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
     CE: 1.5
  • 3:00 PM - 3:30 PM EDT
    Coffee & Networking Break
  • 3:30 PM - 5:00 PM EDT
    Symposium 15: Rethinking Bridging: Understanding the Role of Modeling & Simulation & Strategic Approaches for Bridging Drug-Device Combinations

    Co-Chair & Faculty: Joga Gobburu, PhD – Univ of Maryland, Baltimore

    Co-Chair & Faculty: Amir S. Youssef, PhD – GlaxoSmithKline plc

    Faculty: Zhe Li, PhD – US Food & Drug Administration

    Faculty: Sandra Suarez-Sharp, PhD – Simulations Plus

  • 3:30 PM - 5:00 PM EDT
    Symposium 15: Rethinking Bridging: Understanding the Role of Modeling & Simulation and Strategic Approaches for Bridging Drug-Device Combinations
    Co-Chair & Faculty: Joga Gobburu, PhD – Univ of Maryland, Baltimore
    Co-Chair & Faculty: Amir S. Youssef, PhD – GlaxoSmithKline plc
    Faculty: Sandra Suarez-Sharp, PhD – Simulations Plus
    Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
     CE: 1.5